440 related articles for article (PubMed ID: 12110620)
1. Aristolochic acid as a probable human cancer hazard in herbal remedies: a review.
Arlt VM; Stiborova M; Schmeiser HH
Mutagenesis; 2002 Jul; 17(4):265-77. PubMed ID: 12110620
[TBL] [Abstract][Full Text] [Related]
2. Exceptionally long-term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy.
Schmeiser HH; Nortier JL; Singh R; Gamboa da Costa G; Sennesael J; Cassuto-Viguier E; Ambrosetti D; Rorive S; Pozdzik A; Phillips DH; Stiborova M; Arlt VM
Int J Cancer; 2014 Jul; 135(2):502-7. PubMed ID: 24921086
[TBL] [Abstract][Full Text] [Related]
3. The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.
Stiborova M; Frei E; Arlt VM; Schmeiser HH
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Mar; 153(1):5-11. PubMed ID: 19365519
[TBL] [Abstract][Full Text] [Related]
4. 32P-post-labelling analysis of DNA adducts formed by aristolochic acid in tissues from patients with Chinese herbs nephropathy.
Bieler CA; Stiborova M; Wiessler M; Cosyns JP; van Ypersele de Strihou C; Schmeiser HH
Carcinogenesis; 1997 May; 18(5):1063-7. PubMed ID: 9163697
[TBL] [Abstract][Full Text] [Related]
5. Co-Exposure to Aristolochic Acids I and II Increases DNA Adduct Formation Responsible for Aristolochic Acid I-Mediated Carcinogenicity in Rats.
Bárta F; Dedíková A; Bebová M; Dušková Š; Mráz J; Schmeiser HH; Arlt VM; Hodek P; Stiborová M
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638820
[TBL] [Abstract][Full Text] [Related]
6. Chemical and molecular basis of the carcinogenicity of Aristolochia plants.
Schmeiser HH; Stiborovà M; Arlt VM
Curr Opin Drug Discov Devel; 2009 Jan; 12(1):141-8. PubMed ID: 19152223
[TBL] [Abstract][Full Text] [Related]
7. Translesional synthesis on DNA templates containing site-specifically placed deoxyadenosine and deoxyguanosine adducts formed by the plant carcinogen aristolochic acid.
Broschard TH; Wiessler M; von der Lieth CW; Schmeiser HH
Carcinogenesis; 1994 Oct; 15(10):2331-40. PubMed ID: 7955074
[TBL] [Abstract][Full Text] [Related]
8. Carcinogenic and nephrotoxic alkaloids aristolochic acids upon activation by NADPH : cytochrome P450 reductase form adducts found in DNA of patients with Chinese herbs nephropathy.
Stiborová M; Hájek M; Frei E; Schmeiser HH
Gen Physiol Biophys; 2001 Dec; 20(4):375-92. PubMed ID: 11989648
[TBL] [Abstract][Full Text] [Related]
9. Aristolochic acid nephropathy: a worldwide problem.
Debelle FD; Vanherweghem JL; Nortier JL
Kidney Int; 2008 Jul; 74(2):158-69. PubMed ID: 18418355
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the mutagenicity of aristolochic acid I and aristolochic acid II in the gpt delta transgenic mouse kidney.
Xing G; Qi X; Chen M; Wu Y; Yao J; Gong L; Nohmi T; Luan Y; Ren J
Mutat Res; 2012 Mar; 743(1-2):52-8. PubMed ID: 22245565
[TBL] [Abstract][Full Text] [Related]
11. Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy.
Stiborová M; Frei E; Sopko B; Wiessler M; Schmeiser HH
Carcinogenesis; 2002 Apr; 23(4):617-25. PubMed ID: 11960915
[TBL] [Abstract][Full Text] [Related]
12. Characterization of DNA adducts formed by aristolochic acids in the target organ (forestomach) of rats by 32P-postlabelling analysis using different chromatographic procedures.
Stiborová M; Fernando RC; Schmeiser HH; Frei E; Pfau W; Wiessler M
Carcinogenesis; 1994 Jun; 15(6):1187-92. PubMed ID: 8020154
[TBL] [Abstract][Full Text] [Related]
13. Comparison of Aristolochic acid I derived DNA adduct levels in human renal toxicity models.
Bastek H; Zubel T; Stemmer K; Mangerich A; Beneke S; Dietrich DR
Toxicology; 2019 May; 420():29-38. PubMed ID: 30940547
[TBL] [Abstract][Full Text] [Related]
14. Using polymerase arrest to detect DNA binding specificity of aristolochic acid in the mouse H-ras gene.
Arlt VM; Wiessler M; Schmeiser HH
Carcinogenesis; 2000 Feb; 21(2):235-42. PubMed ID: 10657963
[TBL] [Abstract][Full Text] [Related]
15. Effect of site-specifically located aristolochic acid DNA adducts on in vitro DNA synthesis by human DNA polymerase alpha.
Broschard TH; Wiessler M; Schmeiser HH
Cancer Lett; 1995 Nov; 98(1):47-56. PubMed ID: 8529205
[TBL] [Abstract][Full Text] [Related]
16. Impact of genetic modulation of SULT1A enzymes on DNA adduct formation by aristolochic acids and 3-nitrobenzanthrone.
Arlt VM; Meinl W; Florian S; Nagy E; Barta F; Thomann M; Mrizova I; Krais AM; Liu M; Richards M; Mirza A; Kopka K; Phillips DH; Glatt H; Stiborova M; Schmeiser HH
Arch Toxicol; 2017 Apr; 91(4):1957-1975. PubMed ID: 27557898
[TBL] [Abstract][Full Text] [Related]
17. Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer.
Arlt VM; Stiborová M; vom Brocke J; Simões ML; Lord GM; Nortier JL; Hollstein M; Phillips DH; Schmeiser HH
Carcinogenesis; 2007 Nov; 28(11):2253-61. PubMed ID: 17434925
[TBL] [Abstract][Full Text] [Related]
18. Aristolochic acid and 'Chinese herbs nephropathy': a review of the evidence to date.
Cosyns JP
Drug Saf; 2003; 26(1):33-48. PubMed ID: 12495362
[TBL] [Abstract][Full Text] [Related]
19. Evidence for reductive activation of carcinogenic aristolochic acids by prostaglandin H synthase -- (32)P-postlabeling analysis of DNA adduct formation.
Stiborová M; Frei E; Breuer A; Wiessler M; Schmeiser HH
Mutat Res; 2001 Jun; 493(1-2):149-60. PubMed ID: 11516724
[TBL] [Abstract][Full Text] [Related]
20. Comparison of DNA adduct formation by aristolochic acids in various in vitro activation systems by 32P-post-labelling: evidence for reductive activation by peroxidases.
Schmeiser HH; Frei E; Wiessler M; Stiborova M
Carcinogenesis; 1997 May; 18(5):1055-62. PubMed ID: 9163696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]